• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023

    4/13/23 11:00:36 AM ET
    $AVGO
    $BX
    $CCCS
    $CFRX
    Semiconductors
    Technology
    Investment Managers
    Finance
    Get the next $AVGO alert in real time by email

    Upgrades

    UBS upgraded the previous rating for Ingredion Inc (NYSE:INGR) from Neutral to Buy. For the fourth quarter, Ingredion had an EPS of $1.65, compared to year-ago quarter EPS of $1.09. At the moment, the stock has a 52-week-high of $105.24 and a 52-week-low of $78.86. Ingredion closed at $101.56 at the end of the last trading period.

    For Montauk Renewables Inc (NASDAQ:MNTK), UBS upgraded the previous rating of Sell to Neutral. For the fourth quarter, Montauk Renewables had an EPS of $0.05, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $20.78 and a 52-week-low of $6.58. Montauk Renewables closed at $7.00 at the end of the last trading period.

    Maxim Group upgraded the previous rating for ContraFect Corp (NASDAQ:CFRX) from Hold to Buy. For the fourth quarter, ContraFect had an EPS of $16.14, compared to year-ago quarter EPS of $8.80. The current stock performance of ContraFect shows a 52-week-high of $362.40 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $1.01.

    For Blackstone Inc (NYSE:BX), Oppenheimer upgraded the previous rating of Perform to Outperform. Blackstone earned $1.07 in the fourth quarter, compared to $1.71 in the year-ago quarter. The stock has a 52-week-high of $126.75 and a 52-week-low of $71.73. At the end of the last trading period, Blackstone closed at $82.61.

    For VF Corp (NYSE:VFC), Edward Jones upgraded the previous rating of Hold to Buy. In the third quarter, VF showed an EPS of $1.12, compared to $1.35 from the year-ago quarter. At the moment, the stock has a 52-week-high of $58.79 and a 52-week-low of $20.03. VF closed at $21.57 at the end of the last trading period.

    Exane BNP Paribas upgraded the previous rating for DraftKings Inc (NASDAQ:DKNG) from Underperform to Neutral. DraftKings earned $0.53 in the fourth quarter, compared to $0.80 in the year-ago quarter. The stock has a 52-week-high of $21.62 and a 52-week-low of $9.78. At the end of the last trading period, DraftKings closed at $18.53.

    Scotiabank upgraded the previous rating for Chevron Corp (NYSE:CVX) from Sector Perform to Sector Outperform. In the fourth quarter, Chevron showed an EPS of $4.09, compared to $2.56 from the year-ago quarter. The stock has a 52-week-high of $189.66 and a 52-week-low of $132.54. At the end of the last trading period, Chevron closed at $169.82.

    According to Scotiabank, the prior rating for EOG Resources Inc (NYSE:EOG) was changed from Sector Perform to Sector Outperform. EOG Resources earned $3.30 in the fourth quarter, compared to $3.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $150.78 and a 52-week-low of $92.22. EOG Resources closed at $122.31 at the end of the last trading period.

    According to B of A Securities, the prior rating for SunPower Corp (NASDAQ:SPWR) was changed from Underperform to Neutral. In the fourth quarter, SunPower showed an EPS of $0.15, compared to $0.07 from the year-ago quarter. The current stock performance of SunPower shows a 52-week-high of $28.33 and a 52-week-low of $12.03. Moreover, at the end of the last trading period, the closing price was at $13.07.

    Morgan Stanley upgraded the previous rating for World Wrestling Entertainment Inc (NYSE:WWE) from Equal-Weight to Overweight. For the fourth quarter, World Wrestling Enter had an EPS of $0.52, compared to year-ago quarter EPS of $0.70. At the moment, the stock has a 52-week-high of $103.97 and a 52-week-low of $55.13. World Wrestling Enter closed at $102.78 at the end of the last trading period.

    According to Citigroup, the prior rating for Steven Madden Ltd (NASDAQ:SHOO) was changed from Neutral to Buy. For the fourth quarter, Steven Madden had an EPS of $0.44, compared to year-ago quarter EPS of $0.87. At the moment, the stock has a 52-week-high of $45.00 and a 52-week-low of $26.36. Steven Madden closed at $34.10 at the end of the last trading period.

    Citigroup upgraded the previous rating for Merck & Co Inc (NYSE:MRK) from Neutral to Buy. For the fourth quarter, Merck & Co had an EPS of $1.62, compared to year-ago quarter EPS of $1.80. At the moment, the stock has a 52-week-high of $115.49 and a 52-week-low of $83.06. Merck & Co closed at $113.75 at the end of the last trading period.

    See all analyst ratings upgrades.

    Downgrades

    For DLocal Ltd (NASDAQ:DLO), HSBC downgraded the previous rating of Buy to Hold. In the fourth quarter, DLocal showed an EPS of $0.06, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $33.56 and a 52-week-low of $9.04. At the end of the last trading period, DLocal closed at $13.55.

    According to Craig-Hallum, the prior rating for Sportsman's Warehouse Holdings Inc (NASDAQ:SPWH) was changed from Buy to Hold. Sportsman's Warehouse earned $0.33 in the fourth quarter, compared to $0.49 in the year-ago quarter. The current stock performance of Sportsman's Warehouse shows a 52-week-high of $11.37 and a 52-week-low of $7.66. Moreover, at the end of the last trading period, the closing price was at $8.31.

    For National Instruments Corp (NASDAQ:NATI), Susquehanna downgraded the previous rating of Positive to Neutral. For the fourth quarter, National Instruments had an EPS of $0.63, compared to year-ago quarter EPS of $0.60. The stock has a 52-week-high of $57.99 and a 52-week-low of $29.81. At the end of the last trading period, National Instruments closed at $57.68.

    For JD.com Inc (NASDAQ:JD), UBS downgraded the previous rating of Buy to Neutral. JD.com earned $0.70 in the fourth quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $68.29 and a 52-week-low of $33.17. JD.com closed at $36.95 at the end of the last trading period.

    According to Morgan Stanley, the prior rating for National Instruments Corp (NASDAQ:NATI) was changed from to Equal-Weight. For the fourth quarter, National Instruments had an EPS of $0.63, compared to year-ago quarter EPS of $0.60. The stock has a 52-week-high of $57.99 and a 52-week-low of $29.81. At the end of the last trading period, National Instruments closed at $57.68.

    For Exxon Mobil Corp (NYSE:XOM), Scotiabank downgraded the previous rating of Sector Outperform to Sector Perform. Exxon Mobil earned $3.40 in the fourth quarter, compared to $2.05 in the year-ago quarter. The stock has a 52-week-high of $119.63 and a 52-week-low of $79.29. At the end of the last trading period, Exxon Mobil closed at $115.23.

    According to B of A Securities, the prior rating for Playtika Holding Corp (NASDAQ:PLTK) was changed from Neutral to Underperform. In the fourth quarter, Playtika Holding showed an EPS of $0.24, compared to $0.25 from the year-ago quarter. At the moment, the stock has a 52-week-high of $20.29 and a 52-week-low of $7.83. Playtika Holding closed at $11.65 at the end of the last trading period.

    Deutsche Bank downgraded the previous rating for First Solar Inc (NASDAQ:FSLR) from Buy to Hold. First Solar earned $0.07 in the fourth quarter, compared to $1.23 in the year-ago quarter. The current stock performance of First Solar shows a 52-week-high of $219.55 and a 52-week-low of $59.60. Moreover, at the end of the last trading period, the closing price was at $207.89.

    According to William Blair, the prior rating for Tessco Technologies Inc (NASDAQ:TESS) was changed from Outperform to Market Perform. Tessco Technologies earned $0.05 in the third quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Tessco Technologies shows a 52-week-high of $8.79 and a 52-week-low of $4.03. Moreover, at the end of the last trading period, the closing price was at $8.79.

    For LyondellBasell Industries NV (NYSE:LYB), Jefferies downgraded the previous rating of Buy to Hold. In the fourth quarter, LyondellBasell Industries showed an EPS of $1.29, compared to $3.63 from the year-ago quarter. The current stock performance of LyondellBasell Industries shows a 52-week-high of $117.16 and a 52-week-low of $71.50. Moreover, at the end of the last trading period, the closing price was at $97.21.

    According to Jefferies, the prior rating for LSB Industries Inc (NYSE:LXU) was changed from Buy to Hold. LSB Industries earned $0.90 in the fourth quarter, compared to $0.72 in the year-ago quarter. The stock has a 52-week-high of $27.18 and a 52-week-low of $9.26. At the end of the last trading period, LSB Industries closed at $10.01.

    According to Wolfe Research, the prior rating for National Storage Affiliates Trust (NYSE:NSA) was changed from Peer Perform to Underperform. National Storage earned $0.71 in the fourth quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $67.44 and a 52-week-low of $34.90. National Storage closed at $42.72 at the end of the last trading period.

    Wolfe Research downgraded the previous rating for CubeSmart (NYSE:CUBE) from Outperform to Peer Perform. For the fourth quarter, CubeSmart had an EPS of $0.67, compared to year-ago quarter EPS of $0.58. At the moment, the stock has a 52-week-high of $54.94 and a 52-week-low of $36.85. CubeSmart closed at $48.19 at the end of the last trading period.

    Wolfe Research downgraded the previous rating for Life Storage Inc (NYSE:LSI) from Outperform to Peer Perform. Life Storage earned $1.69 in the fourth quarter, compared to $1.41 in the year-ago quarter. The current stock performance of Life Storage shows a 52-week-high of $151.75 and a 52-week-low of $94.02. Moreover, at the end of the last trading period, the closing price was at $144.55.

    See all analyst ratings downgrades.

    Initiations

    With an Outperform rating, Noble Capital Markets initiated coverage on Snail Inc (NASDAQ:SNAL). The price target seems to have been set at $9.00 for Snail. NoneAt the moment, the stock has a 52-week-high of $4.36 and a 52-week-low of $1.11. Snail closed at $1.11 at the end of the last trading period.

    With a Buy rating, Craig-Hallum initiated coverage on OmniAb Inc (NASDAQ:OABI). The price target seems to have been set at $10.00 for OmniAb. OmniAb earned $0.07 in the fourth quarter, compared to $0.04 in the year-ago quarter. The current stock performance of OmniAb shows a 52-week-high of $5.07 and a 52-week-low of $1.91. Moreover, at the end of the last trading period, the closing price was at $3.81.

    With a Neutral rating, Janney Montgomery Scott initiated coverage on Peoples Bancorp Inc (Marietta OH) (NASDAQ:PEBO). The price target seems to have been set at $28.00 for Peoples Bancorp. Peoples Bancorp earned $0.95 in the fourth quarter, compared to $0.97 in the year-ago quarter. The stock has a 52-week-high of $32.22 and a 52-week-low of $25.09. At the end of the last trading period, Peoples Bancorp closed at $25.44.

    Canaccord Genuity initiated coverage on Intellia Therapeutics Inc (NASDAQ:NTLA) with a Buy rating. The price target for Intellia Therapeutics is set to $66.00. In the fourth quarter, Intellia Therapeutics showed an EPS of $1.40, compared to $1.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $76.24 and a 52-week-low of $32.44. Intellia Therapeutics closed at $34.58 at the end of the last trading period.

    With a Buy rating, Canaccord Genuity initiated coverage on Verve Therapeutics Inc (NASDAQ:VERV). The price target seems to have been set at $29.00 for Verve Therapeutics. In the fourth quarter, Verve Therapeutics showed an EPS of $0.67, compared to $0.65 from the year-ago quarter. The current stock performance of Verve Therapeutics shows a 52-week-high of $42.86 and a 52-week-low of $10.70. Moreover, at the end of the last trading period, the closing price was at $13.69.

    Cantor Fitzgerald initiated coverage on CRISPR Therapeutics AG (NASDAQ:CRSP) with an Overweight rating. The price target for CRISPR Therapeutics is set to $72.00. For the fourth quarter, CRISPR Therapeutics had an EPS of $1.41, compared to year-ago quarter EPS of $1.84. The current stock performance of CRISPR Therapeutics shows a 52-week-high of $86.79 and a 52-week-low of $38.94. Moreover, at the end of the last trading period, the closing price was at $43.47.

    With a Buy rating, HC Wainwright & Co. initiated coverage on FTC Solar Inc (NASDAQ:FTCI). The price target seems to have been set at $5.00 for FTC Solar. FTC Solar earned $0.11 in the fourth quarter, compared to $0.17 in the year-ago quarter. The current stock performance of FTC Solar shows a 52-week-high of $6.13 and a 52-week-low of $1.78. Moreover, at the end of the last trading period, the closing price was at $2.74.

    JP Morgan initiated coverage on CCC Intelligent Solutions Holdings Inc (NASDAQ:CCCS) with an Overweight rating. The price target for CCC Intelligent Solutions is set to $11.00. For the fourth quarter, CCC Intelligent Solutions had an EPS of $0.07, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $10.19 and a 52-week-low of $7.42. At the end of the last trading period, CCC Intelligent Solutions closed at $8.58.

    JP Morgan initiated coverage on Plymouth Industrial REIT Inc (NYSE:PLYM) with a Neutral rating. The price target for Plymouth Industrial REIT is set to $23.00. For the fourth quarter, Plymouth Industrial REIT had an EPS of $0.42, compared to year-ago quarter EPS of $0.39. The current stock performance of Plymouth Industrial REIT shows a 52-week-high of $26.23 and a 52-week-low of $15.59. Moreover, at the end of the last trading period, the closing price was at $20.62.

    With a Buy rating, B. Riley Securities initiated coverage on PubMatic Inc (NASDAQ:PUBM). The price target seems to have been set at $20.00 for PubMatic. For the fourth quarter, PubMatic had an EPS of $0.33, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $26.75 and a 52-week-low of $12.19. At the end of the last trading period, PubMatic closed at $13.81.

    With a Buy rating, B. Riley Securities initiated coverage on Magnite Inc (NASDAQ:MGNI). The price target seems to have been set at $15.00 for Magnite. For the fourth quarter, Magnite had an EPS of $0.24, compared to year-ago quarter EPS of $0.26. The current stock performance of Magnite shows a 52-week-high of $14.21 and a 52-week-low of $5.58. Moreover, at the end of the last trading period, the closing price was at $8.65.

    Baird initiated coverage on Pliant Therapeutics Inc (NASDAQ:PLRX) with an Outperform rating. The price target for Pliant Therapeutics is set to $44.00. In the fourth quarter, Pliant Therapeutics showed an EPS of $0.72, compared to $0.68 from the year-ago quarter. At the moment, the stock has a 52-week-high of $36.64 and a 52-week-low of $3.96. Pliant Therapeutics closed at $25.40 at the end of the last trading period.

    With a Strong Buy rating, Raymond James initiated coverage on Primerica Inc (NYSE:PRI). The price target seems to have been set at $244.00 for Primerica. In the fourth quarter, Primerica showed an EPS of $3.49, compared to $2.94 from the year-ago quarter. The current stock performance of Primerica shows a 52-week-high of $195.69 and a 52-week-low of $110.32. Moreover, at the end of the last trading period, the closing price was at $172.35.

    Benchmark initiated coverage on Broadcom Inc (NASDAQ:AVGO) with a Buy rating. The price target for Broadcom is set to $770.00. Broadcom earned $10.33 in the first quarter, compared to $8.39 in the year-ago quarter. The current stock performance of Broadcom shows a 52-week-high of $648.50 and a 52-week-low of $415.35. Moreover, at the end of the last trading period, the closing price was at $616.70.

    With an Outperform rating, Raymond James initiated coverage on Relay Therapeutics Inc (NASDAQ:RLAY). The price target seems to have been set at $29.00 for Relay Therapeutics. For the fourth quarter, Relay Therapeutics had an EPS of $0.56, compared to year-ago quarter EPS of $0.62. The current stock performance of Relay Therapeutics shows a 52-week-high of $33.05 and a 52-week-low of $12.71. Moreover, at the end of the last trading period, the closing price was at $16.01.

    William Blair initiated coverage on Costco Wholesale Corp (NASDAQ:COST) with an Outperform rating. For the second quarter, Costco Wholesale had an EPS of $3.30, compared to year-ago quarter EPS of $2.92. The stock has a 52-week-high of $609.18 and a 52-week-low of $406.64. At the end of the last trading period, Costco Wholesale closed at $489.35.

    Mizuho initiated coverage on General Motors Co (NYSE:GM) with a Neutral rating. The price target for General Motors is set to $39.00. In the fourth quarter, General Motors showed an EPS of $2.12, compared to $1.35 from the year-ago quarter. At the moment, the stock has a 52-week-high of $43.63 and a 52-week-low of $30.34. General Motors closed at $34.62 at the end of the last trading period.

    With an Outperform rating, Oppenheimer initiated coverage on RxSight Inc (NASDAQ:RXST). The price target seems to have been set at $23.00 for RxSight. In the fourth quarter, RxSight showed an EPS of $0.45, compared to $0.47 from the year-ago quarter. At the moment, the stock has a 52-week-high of $17.73 and a 52-week-low of $9.78. RxSight closed at $17.28 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $AVGO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVGO
    $BX
    $CCCS
    $CFRX

    CompanyDatePrice TargetRatingAnalyst
    DraftKings Inc.
    $DKNG
    2/6/2026$41.00 → $32.00Outperform
    Bernstein
    Steven Madden Ltd.
    $SHOO
    2/5/2026$30.00Hold → Underperform
    Jefferies
    Exxon Mobil Corporation
    $XOM
    2/3/2026$125.00Neutral → Underperform
    BNP Paribas Exane
    Exxon Mobil Corporation
    $XOM
    2/3/2026$135.00 → $145.00Buy
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$160.00 → $168.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$180.00Buy → Hold
    HSBC Securities
    RxSight Inc.
    $RXST
    1/30/2026Mkt Perform
    William Blair
    Broadcom Inc.
    $AVGO
    1/30/2026$400.00Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $AVGO
    $BX
    $CCCS
    $CFRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Patel Naimish bought $49,704 worth of shares (1,508 units at $32.96) (SEC Form 4)

    4 - CRISPR Therapeutics AG (0001674416) (Issuer)

    1/27/26 5:35:15 PM ET
    $CRSP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Beam S Craig bought $4,969 worth of shares (157 units at $31.65), increasing direct ownership by 0.59% to 26,665 units (SEC Form 4)

    4 - PEOPLES BANCORP INC (0000318300) (Issuer)

    1/23/26 2:11:54 PM ET
    $PEBO
    Major Banks
    Finance

    Director Smith Dwight Eric bought $16,310 worth of shares (500 units at $32.62), increasing direct ownership by 6% to 8,199 units (SEC Form 4)

    4 - PEOPLES BANCORP INC (0000318300) (Issuer)

    1/23/26 11:09:47 AM ET
    $PEBO
    Major Banks
    Finance

    $AVGO
    $BX
    $CCCS
    $CFRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bernstein reiterated coverage on DraftKings with a new price target

    Bernstein reiterated coverage of DraftKings with a rating of Outperform and set a new price target of $32.00 from $41.00 previously

    2/6/26 8:25:47 AM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Steven Madden downgraded by Jefferies with a new price target

    Jefferies downgraded Steven Madden from Hold to Underperform and set a new price target of $30.00

    2/5/26 6:56:13 AM ET
    $SHOO
    Shoe Manufacturing
    Consumer Discretionary

    Exxon Mobil downgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane downgraded Exxon Mobil from Neutral to Underperform and set a new price target of $125.00

    2/3/26 6:52:02 AM ET
    $XOM
    Integrated oil Companies
    Energy

    $AVGO
    $BX
    $CCCS
    $CFRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PubMatic Appoints Marketing Veteran John Petralia as Chief Marketing Officer to Accelerate AI-Driven Growth

    Appointment strengthens commercial leadership as PubMatic scales AI-powered advertising across CTV, mobile and omnichannel media. PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, today announced the appointment of John Petralia as Chief Marketing Officer. Petralia will lead PubMatic's global marketing organization as the company scales AI-powered advertising technology across premium connected TV (CTV), mobile app, and omnichannel media. His appointment comes as publishers and brands move from AI experimentation to live, measurable execution – placing new emphasis on clarity, measurable performance, and trusted scalability. His

    2/12/26 8:00:00 AM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    Steve Madden Announces Fourth Quarter and Fiscal Year End 2025 Earnings Release Date

    LONG ISLAND CITY, N.Y., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Steven Madden, Ltd. (NASDAQ:SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced that the Company plans to release its fourth quarter and fiscal year end 2025 earnings results on Wednesday, February 25, 2026. Management will host a conference call to review the results at 8:30 a.m. Eastern Time. The live webcast of the management call can be accessed at the Company's investor relations website at https://investor.stevemadden.com or by using the following link https://edge.media-server.com/mmc/p/iirmqugn. The webcast is listen-only. Those interested in participating in the ques

    2/12/26 6:59:00 AM ET
    $SHOO
    Shoe Manufacturing
    Consumer Discretionary

    EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

    The EGFR-NSCLC market is expected to grow owing to the approval of new agents such as Zipalertinib (Cullinan Oncology/Taiho Pharma), Ivonescimab (Akeso Biopharma/Summit Therapeutics), Sacituzumab Tirumotecan (Merck/Kelun-Biotech), Izalontamab Brengitecan (Bristol-Myers Squibb), Firmonertinib (ArriVent BioPharma), and others in frontline and combination settings, rising therapy costs, and increasing testing rates that enable the identification of more patients with EGFR alterations. LAS VEGAS, Feb. 11, 2026 /PRNewswire/ -- DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individua

    2/11/26 5:31:00 PM ET
    $ABBV
    $AVBP
    $BDTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $AVGO
    $BX
    $CCCS
    $CFRX
    SEC Filings

    View All

    Primerica Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits, Regulation FD Disclosure

    8-K - Primerica, Inc. (0001475922) (Filer)

    2/11/26 4:27:55 PM ET
    $PRI
    Life Insurance
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Intellia Therapeutics Inc.

    SCHEDULE 13G/A - Intellia Therapeutics, Inc. (0001652130) (Subject)

    2/11/26 1:18:54 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 144 filed by Ingredion Incorporated

    144 - Ingredion Inc (0001046257) (Subject)

    2/11/26 11:17:12 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    $AVGO
    $BX
    $CCCS
    $CFRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Zallie James P. was granted 58,096 shares and covered exercise/tax liability with 24,499 shares, increasing direct ownership by 67% to 83,764 units (SEC Form 4)

    4 - Ingredion Inc (0001046257) (Issuer)

    2/11/26 7:36:13 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    SVP and Chief HR Officer Wolfe Nancy was granted 6,355 shares and covered exercise/tax liability with 1,924 shares, increasing direct ownership by 35% to 17,103 units (SEC Form 4)

    4 - Ingredion Inc (0001046257) (Issuer)

    2/11/26 7:32:10 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    SVP, Global Ops and CSCO Seip David Eric covered exercise/tax liability with 1,101 shares and was granted 3,290 shares, increasing direct ownership by 8% to 28,421 units (SEC Form 4)

    4 - Ingredion Inc (0001046257) (Issuer)

    2/11/26 7:30:28 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    $AVGO
    $BX
    $CCCS
    $CFRX
    Leadership Updates

    Live Leadership Updates

    View All

    PubMatic Appoints Marketing Veteran John Petralia as Chief Marketing Officer to Accelerate AI-Driven Growth

    Appointment strengthens commercial leadership as PubMatic scales AI-powered advertising across CTV, mobile and omnichannel media. PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, today announced the appointment of John Petralia as Chief Marketing Officer. Petralia will lead PubMatic's global marketing organization as the company scales AI-powered advertising technology across premium connected TV (CTV), mobile app, and omnichannel media. His appointment comes as publishers and brands move from AI experimentation to live, measurable execution – placing new emphasis on clarity, measurable performance, and trusted scalability. His

    2/12/26 8:00:00 AM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    Ingredion Appoints President and CEO James P. Zallie as Chairman of the Board

    WESTCHESTER, Ill., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE:INGR), a leading global provider of ingredient solutions, today announced that its board of directors has unanimously elected Jim Zallie, president and CEO, to assume the additional role of chairman of the board, effective immediately. "I am honored by the board's confidence and grateful for the opportunity to serve as Chairman. Ingredion has a strong foundation, a talented global team, and a clear strategy focused on becoming the go-to provider of texture solutions that make healthy taste better," said Jim Zallie. "I look forward to continuing to work closely with the board as we execute our growth agenda a

    2/11/26 9:00:00 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    PubMatic Expands Commercial Leadership Team to Accelerate Buy-Side and Publisher Growth

    New executive and senior leadership appointments deepen PubMatic's brand, agency, and publisher partnerships across CTV, mobile app, and omnichannel media PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, today announced a major expansion of its commercial leadership team, signaling the company's next phase of growth as demand accelerates for AI-driven buying across premium connected TV (CTV), mobile app, and omnichannel media. Anchored by the strategic appointments of Joseph Dressler as Senior Vice President, Advertiser Solutions (Brands) and Bill McLaughlin as Senior Vice President, Advertiser Solutions (Agencies), the expanded

    1/27/26 9:00:00 AM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    $AVGO
    $BX
    $CCCS
    $CFRX
    Financials

    Live finance-specific insights

    View All

    Steve Madden Announces Fourth Quarter and Fiscal Year End 2025 Earnings Release Date

    LONG ISLAND CITY, N.Y., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Steven Madden, Ltd. (NASDAQ:SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced that the Company plans to release its fourth quarter and fiscal year end 2025 earnings results on Wednesday, February 25, 2026. Management will host a conference call to review the results at 8:30 a.m. Eastern Time. The live webcast of the management call can be accessed at the Company's investor relations website at https://investor.stevemadden.com or by using the following link https://edge.media-server.com/mmc/p/iirmqugn. The webcast is listen-only. Those interested in participating in the ques

    2/12/26 6:59:00 AM ET
    $SHOO
    Shoe Manufacturing
    Consumer Discretionary

    RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the fourth quarter and full year 2025 after the market close on Wednesday, February 25, 2026. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participate in the conference call, please dial (800) 715-9871 or (646) 307-1963, and enter the conference code: 3406720. The call will also be broadcast live in listen-only mode via a link on the company's investor relations we

    2/11/26 4:10:00 PM ET
    $RXST
    Ophthalmic Goods
    Health Care

    LSB Industries, Inc. Schedules 2025 Fourth Quarter and Full Year Results Release for Wednesday, February 25th and Conference Call for Thursday, February 26th

    LSB Industries, Inc. ("LSB") (NYSE:LXU), today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025 on February, 25, 2026 after the close of the stock market. LSB's management will host a conference call on Thursday, February, 26, 2026 at 10:00 am ET / 9:00 am CT to discuss these results. Participating in the call will be Chairman & Chief Executive Officer, Mark Behrman, Executive Vice President & Chief Financial Officer, Cheryl Maguire and Executive Vice President & Chief Commercial Officer, Damien Renwick. Interested parties may participate in the call by dialing (877) 407-6176 / (201) 689-8451. Please call in 10 minutes befor

    2/11/26 8:30:00 AM ET
    $LXU
    Major Chemicals
    Basic Materials

    $AVGO
    $BX
    $CCCS
    $CFRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by CRISPR Therapeutics AG

    SC 13G/A - CRISPR Therapeutics AG (0001674416) (Subject)

    12/10/24 1:34:45 PM ET
    $CRSP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13D filed by First Solar Inc.

    SC 13D - FIRST SOLAR, INC. (0001274494) (Subject)

    12/10/24 1:11:10 PM ET
    $FSLR
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by Playtika Holding Corp.

    SC 13D/A - Playtika Holding Corp. (0001828016) (Subject)

    11/27/24 7:48:58 PM ET
    $PLTK
    EDP Services
    Technology

    $AVGO
    $BX
    $CCCS
    $CFRX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Exxon Mobil Corporation on Jun 20

    Director Dreyfus Maria S. bought $2,000,386 worth of shares (18,310 units at $109.25), increasing direct ownership by 105% to 35,757 units (SEC Form 4) on June 20, 2024. This substantial insider purchase is a significant development for Exxon Mobil Corporation. As we delve into the recent insider activity at Exxon Mobil, we notice a few interesting patterns. Prior to Dreyfus Maria S.'s purchase, we observed that on January 4, 2024, Ubben Jeffrey W. granted 2,500 shares, which could signal confidence in the company. On the same day, Powell Dina H. claimed no ownership of stock but was granted 8,000 shares, indicating a new ownership stake. These events suggest a mix of adjustments in holding

    6/20/24 1:39:11 PM ET
    $XOM
    Integrated oil Companies
    Energy